The patent badge is an abbreviated version of the USPTO patent document. The patent badge does contain a link to the full patent document.

The patent badge is an abbreviated version of the USPTO patent document. The patent badge covers the following: Patent number, Date patent was issued, Date patent was filed, Title of the patent, Applicant, Inventor, Assignee, Attorney firm, Primary examiner, Assistant examiner, CPCs, and Abstract. The patent badge does contain a link to the full patent document (in Adobe Acrobat format, aka pdf). To download or print any patent click here.

Date of Patent:
Jun. 23, 2015

Filed:

Jan. 25, 2012
Applicants:

Fumihito Sugihara, Yao, JP;

Naoki Inoue, Yao, JP;

Seiko Koizumi, Yao, JP;

Tadashi Yoshimoto, Nara, JP;

Hiroshi Oyama, Hirakata, JP;

Inventors:

Fumihito Sugihara, Yao, JP;

Naoki Inoue, Yao, JP;

Seiko Koizumi, Yao, JP;

Tadashi Yoshimoto, Nara, JP;

Hiroshi Oyama, Hirakata, JP;

Assignee:

NITTA GELATIN INC., Osaka, JP;

Attorneys:
Primary Examiner:
Assistant Examiner:
Int. Cl.
CPC ...
A61K 38/39 (2006.01); A61K 38/05 (2006.01); A61K 38/06 (2006.01); C07K 5/062 (2006.01); C07K 5/065 (2006.01); C07K 5/072 (2006.01); C07K 5/083 (2006.01); C07K 5/087 (2006.01); C07K 5/093 (2006.01); C07K 5/097 (2006.01);
U.S. Cl.
CPC ...
A61K 38/39 (2013.01); A61K 38/05 (2013.01); A61K 38/06 (2013.01); C07K 5/06043 (2013.01); C07K 5/0606 (2013.01); C07K 5/06078 (2013.01); C07K 5/06104 (2013.01); C07K 5/0806 (2013.01); C07K 5/0812 (2013.01); C07K 5/0819 (2013.01); C07K 5/0823 (2013.01);
Abstract

A collagen peptide mixture containing three or more kinds selected from Glu-Hyp-Gly, Glu-Hyp, Leu-Hyp-Gly, Pro-Ala, Ser-Hyp, Ala-Hyp-Gly, chemically-modified substances thereof and pharmaceutically acceptable salts thereof, and at least one peptide selected from the group consisting of Glu-Hyp-Gly, Glu-Hyp, Leu-Hyp-Gly, Pro-Ala, Ser-Hyp, Ala-Hyp-Gly, Pro-Hyp-Gly, Leu-Hyp, Ile-Hyp, Ser-Hyp-Gly, Gly-Pro-Hyp, (Pro-Hyp-Gly), Pro-Hyp, Hyp-Gly, Pro-Gly, Pro-Pro and Ala-Hyp or a chemically-modified substance thereof or a pharmaceutically acceptable salt thereof have DPPTV inhibitory activity and/or GLP-1 secretion accelerating activity, and hence are effective as a therapeutic or preventive agent or the like for diabetes.


Find Patent Forward Citations

Loading…